221 related articles for article (PubMed ID: 15253763)
1. Interstitial deletion of 10p and atrial septal defect in DiGeorge 2 syndrome.
Yatsenko SA; Yatsenko AN; Szigeti K; Craigen WJ; Stankiewicz P; Cheung SW; Lupski JR
Clin Genet; 2004 Aug; 66(2):128-36. PubMed ID: 15253763
[TBL] [Abstract][Full Text] [Related]
2. Molecular cytogenetic characterization of a 10p14 deletion that includes the DGS2 region in a patient with multiple anomalies.
Skrypnyk C; Goecke TO; Majewski F; Bartsch O
Am J Med Genet; 2002 Nov; 113(2):207-12. PubMed ID: 12407714
[TBL] [Abstract][Full Text] [Related]
3. Dual-probe fluorescence in situ hybridization assay for detecting deletions associated with VCFS/DiGeorge syndrome I and DiGeorge syndrome II loci.
Berend SA; Spikes AS; Kashork CD; Wu JM; Daw SC; Scambler PJ; Shaffer LG
Am J Med Genet; 2000 Apr; 91(4):313-7. PubMed ID: 10766989
[TBL] [Abstract][Full Text] [Related]
4. A common region of 10p deleted in DiGeorge and velocardiofacial syndromes.
Daw SC; Taylor C; Kraman M; Call K; Mao J; Schuffenhauer S; Meitinger T; Lipson T; Goodship J; Scambler P
Nat Genet; 1996 Aug; 13(4):458-60. PubMed ID: 8696341
[TBL] [Abstract][Full Text] [Related]
5. DiGeorge anomaly and chromosome 10p deletions: one or two loci?
Dasouki M; Jurecic V; Phillips JA; Whitlock JA; Baldini A
Am J Med Genet; 1997 Nov; 73(1):72-5. PubMed ID: 9375926
[TBL] [Abstract][Full Text] [Related]
6. Deletion mapping on chromosome 10p and definition of a critical region for the second DiGeorge syndrome locus (DGS2).
Schuffenhauer S; Lichtner P; Peykar-Derakhshandeh P; Murken J; Haas OA; Back E; Wolff G; Zabel B; Barisic I; Rauch A; Borochowitz Z; Dallapiccola B; Ross M; Meitinger T
Eur J Hum Genet; 1998; 6(3):213-25. PubMed ID: 9781025
[TBL] [Abstract][Full Text] [Related]
7. Velo-cardio-facial and partial DiGeorge phenotype in a child with interstitial deletion at 10p13--implications for cytogenetics and molecular biology.
Lipson A; Fagan K; Colley A; Colley P; Sholler G; Issacs D; Oates RK
Am J Med Genet; 1996 Nov; 65(4):304-8. PubMed ID: 8923940
[TBL] [Abstract][Full Text] [Related]
8. Expression and mutation analysis of BRUNOL3, a candidate gene for heart and thymus developmental defects associated with partial monosomy 10p.
Lichtner P; Attié-Bitach T; Schuffenhauer S; Henwood J; Bouvagnet P; Scambler PJ; Meitinger T; Vekemans M
J Mol Med (Berl); 2002 Jul; 80(7):431-42. PubMed ID: 12110949
[TBL] [Abstract][Full Text] [Related]
9. Unbalanced inherited complex chromosome rearrangement involving chromosome 8, 10, 11 and 16 in a patient with congenital malformations and delayed development.
Karmous-Benailly H; Giuliano F; Massol C; Bloch C; De Ricaud D; Lambert JC; Perelman S
Eur J Med Genet; 2006; 49(5):431-8. PubMed ID: 16497571
[TBL] [Abstract][Full Text] [Related]
10. The phenotypic spectrum of the 10p deletion syndrome versus the classical DiGeorge syndrome.
Van Esch H; Groenen P; Fryns JP; Van de Ven W; Devriendt K
Genet Couns; 1999; 10(1):59-65. PubMed ID: 10191430
[TBL] [Abstract][Full Text] [Related]
11. Molecular cytogenetic analysis of a series of 23 DiGeorge syndrome patients by fluorescence in situ hybridization.
Demczuk S; Desmaze C; Aikem M; Prieur M; Ledeist F; Sanson M; Rouleau G; Thomas G; Aurias A
Ann Genet; 1994; 37(2):60-5. PubMed ID: 7985979
[TBL] [Abstract][Full Text] [Related]
12. Patient with a 22q11.2 deletion with no overlap of the minimal DiGeorge syndrome critical region (MDGCR).
McQuade L; Christodoulou J; Budarf M; Sachdev R; Wilson M; Emanuel B; Colley A
Am J Med Genet; 1999 Sep; 86(1):27-33. PubMed ID: 10440825
[TBL] [Abstract][Full Text] [Related]
13. DiGeorge syndrome and partial monosomy 10p: case report and review.
Schuffenhauer S; Seidel H; Oechsler H; Belohradsky B; Bernsau U; Murken J; Meitinger T
Ann Genet; 1995; 38(3):162-7. PubMed ID: 8540688
[TBL] [Abstract][Full Text] [Related]
14. Molecular cytogenetic characterization of a subtle interstitial del(3)(p25.3p26.2) in a patient with deletion 3p syndrome.
Cargile CB; Goh DL; Goodman BK; Chen XN; Korenberg JR; Semenza GL; Thomas GH
Am J Med Genet; 2002 Apr; 109(2):133-8. PubMed ID: 11977162
[TBL] [Abstract][Full Text] [Related]
15. An interstitial deletion of 7.1Mb in chromosome band 6p22.3 associated with developmental delay and dysmorphic features including heart defects, short neck, and eye abnormalities.
Bremer A; Schoumans J; Nordenskjöld M; Anderlid BM; Giacobini M
Eur J Med Genet; 2009; 52(5):358-62. PubMed ID: 19576304
[TBL] [Abstract][Full Text] [Related]
16. Additional patient with del(12)(q21.2q22): further evidence for a candidate region for cardio-facio-cutaneous syndrome?
Rauen KA; Albertson DG; Pinkel D; Cotter PD
Am J Med Genet; 2002 Jun; 110(1):51-6. PubMed ID: 12116271
[TBL] [Abstract][Full Text] [Related]
17. Molecular cytogenetic characterization of the DiGeorge syndrome region using fluorescence in situ hybridization.
Lindsay EA; Halford S; Wadey R; Scambler PJ; Baldini A
Genomics; 1993 Aug; 17(2):403-7. PubMed ID: 8406492
[TBL] [Abstract][Full Text] [Related]
18. Hypocalcemia impacts heart failure control in DiGeorge 2 syndrome.
Chao PH; Chao MC; Hwang KP; Chung MY
Acta Paediatr; 2009 Jan; 98(1):195-8. PubMed ID: 18795911
[TBL] [Abstract][Full Text] [Related]
19. DiGeorge anomaly associated with 10p deletion.
Monaco G; Pignata C; Rossi E; Mascellaro O; Cocozza S; Ciccimarra F
Am J Med Genet; 1991 May; 39(2):215-6. PubMed ID: 2063928
[TBL] [Abstract][Full Text] [Related]
20. Molecular and genetic aspects of DiGeorge/velocardiofacial syndrome.
Driscoll DA
Methods Mol Med; 2006; 126():43-55. PubMed ID: 16930005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
